We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
All precious cargo needs a reliable vehicle to get it to its final destination.
Such is the case for messenger RNA, or mRNA, an infamously fragile molecule. In fact, we would not have mRNA COVID-19 vaccines today without a lesser-known technology: lipid nanoparticles, or LNPs, the delivery vehicles that shuttle these molecules into our cells.
